Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program

被引:95
|
作者
Hofvind, Solveig [1 ,2 ]
Ursin, Giske [3 ,4 ,5 ]
Tretli, Steinar [1 ,6 ]
Sebuodegard, Sofie [1 ]
Moller, Bjorn [7 ]
机构
[1] Canc Registry Norway, Dept Res, N-0304 Oslo, Norway
[2] Oslo & Akershus Univ Coll Appl Sci, Oslo, Norway
[3] Canc Registry Norway, N-0304 Oslo, Norway
[4] Univ Oslo, Inst Basic Med Sci, Oslo, Norway
[5] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[6] Norwegian Univ Sci & Technol, Trondhjem, Norway
[7] Canc Registry Norway, Dept Registrat, N-0304 Oslo, Norway
关键词
mammography; mass screening; female; breast neoplasms; mortality; prevention and control; radiography; Norway; epidemiology; MAMMOGRAPHY; IMPACT; NONCOMPLIANCE; EFFICACY; EVALUATE; NORWAY; EUROPE; WOMEN; BIAS;
D O I
10.1002/cncr.28174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality among screened and nonscreened women in the program. METHODS Information on dates of invitation, attendance, breast cancer diagnosis, emigration, death, and cause of death was linked by using unique 11-digit personal identification numbers assigned all inhabitants of Norway at birth or immigration. In total, 699,628 women ages 50 to 69 years without prior a diagnosis of breast cancer were invited to the program from 1996 to 2009 and were followed for breast cancer through 2009 and death through 2010. Incidence-based breast cancer mortality rate ratios (MRRs) were compared between the screened and nonscreened cohorts using a Poisson regression model. The MRRs were adjusted for calendar period, attained age, years since inclusion in the cohorts, and self-selection bias. RESULTS The crude breast cancer mortality rate was 20.7 per 100,000 women-years for the screened cohort compared with 39.7 per 100,000 women-years for the nonscreened cohort, resulting in an MRR of 0.52 (95% confidence interval, 0.47-0.59). The mortality reduction associated with attendance in the program was 43% (MRR, 0.57; 95% confidence interval, 0.51-0.64) after adjusting for calendar period, attained age, years after inclusion in the cohort, and self-selection bias. CONCLUSIONS After 15 years of follow-up, a 43% reduction in mortality was observed among women who attended the national mammographic screening program in Norway. Cancer 2013; 119: 3106-12. (c) 2013 American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
引用
收藏
页码:3106 / 3112
页数:7
相关论文
共 50 条
  • [1] Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study
    Eiliv Lund
    Nicolle Mode
    Marit Waaseth
    Jean-Christophe Thalabard
    BMC Cancer, 13
  • [2] Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study
    Lund, Eiliv
    Mode, Nicolle
    Waaseth, Marit
    Thalabard, Jean-Christophe
    BMC CANCER, 2013, 13
  • [3] Barriers to Accessing Breast Cancer Screening Faced by Participants in a Breast Cancer Navigation Program
    Keegan, Grace
    DiMaggio, Charles
    Crown, Angelena
    Ravenell, Joseph
    Joseph, Kathie-Ann P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S48 - S49
  • [4] The influence of breast density on breast cancer diagnosis: A study of participants in the BC Cancer Breast Screening Program
    Mar, Colin
    Sam, Janette
    McGahan, Colleen E.
    DeVries, Kimberly
    Coldman, Andrew J.
    BRITISH COLUMBIA MEDICAL JOURNAL, 2019, 61 (10): : 376 - 384
  • [5] Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?
    Hofvind, S
    Wang, H
    Thoresen, S
    ACTA ONCOLOGICA, 2004, 43 (05) : 467 - 473
  • [6] Breast cancer correlates in a cohort of breast screening program participants in Riyadh, KSA
    Al-Amri, Fahad A.
    Saeedi, Mohammed Y.
    Al-Tahan, Fatina M.
    Ali, Arwa M.
    Alomary, Shaker A.
    Arafa, Mostafa
    Ibrahim, Ahmed K.
    Kassim, Kassim A.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2015, 27 (02) : 77 - 82
  • [7] Compression forces used in the Norwegian Breast Cancer Screening Program
    Waade, Gunvor G.
    Moshina, Nataliia
    Sebuodegard, Sofie
    Hogg, Peter
    Hofvind, Solveig
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1071):
  • [8] Cost-effectiveness of the Norwegian breast cancer screening program
    van Luijt, P. A.
    Heijnsdijk, E. A. M.
    de Koning, H. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 833 - 840
  • [9] Overdiagnosis of breast cancer in the Norwegian mammography screening program.
    Zahl, PH
    Mæhlen, J
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1865S - 1865S
  • [10] Interval cancer in the Norwegian Breast Cancer Screening Program: is use of HRT of importance?
    Wang, H
    Bjurstam, N
    Bjorndal, H
    Braaten, A
    Eriksen, L
    Skaane, P
    Vitak, B
    Hofvind, S
    Thoresen, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S50 - S50